Literature DB >> 3532331

Treatment of refractory multiple myeloma and considerations for future therapy.

R A Kyle, P R Greipp, M A Gertz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3532331

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

Review 1.  T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.

Authors:  A B Yehuda; R Or; E Naparstek; S Slavin; A Polliack
Journal:  Blut       Date:  1988-05

2.  Bi-weekly vincristine, epirubicin and methylprednisolone in alkylator-refractory multiple myeloma.

Authors:  M Vincent; G Goss; C Sinoff; C Germond; T Bozek; G Helie; T Koski; S Corringham; R Corringham
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse.

Authors:  L S Manning; J D Berger; H L O'Donoghue; G N Sheridan; P G Claringbold; J H Turner
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.